Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes.

influenza macrophages pleural cavity tissue deconvolution transcriptomics

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
19 Dec 2023
Historique:
medline: 15 12 2023
pubmed: 15 12 2023
entrez: 15 12 2023
Statut: ppublish

Résumé

Seasonal influenza results in 3 to 5 million cases of severe disease and 250,000 to 500,000 deaths annually. Macrophages have been implicated in both the resolution and progression of the disease, but the drivers of these outcomes are poorly understood. We probed mouse lung transcriptomic datasets using the Digital Cell Quantifier algorithm to predict immune cell subsets that correlated with mild or severe influenza A virus (IAV) infection outcomes. We identified a unique lung macrophage population that transcriptionally resembled small serosal cavity macrophages and whose presence correlated with mild disease. Until now, the study of serosal macrophage translocation in the context of viral infections has been neglected. Here, we show that pleural macrophages (PMs) migrate from the pleural cavity to the lung after infection with IAV. We found that the depletion of PMs increased morbidity and pulmonary inflammation. There were increased proinflammatory cytokines in the pleural cavity and an influx of neutrophils within the lung. Our results show that PMs are recruited to the lung during IAV infection and contribute to recovery from influenza. This study expands our knowledge of PM plasticity and identifies a source of lung macrophages independent of monocyte recruitment and local proliferation.

Identifiants

pubmed: 38100417
doi: 10.1073/pnas.2300474120
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2300474120

Subventions

Organisme : University of California, Riverside (UCR)
ID : Regents Faculty Fellowship
Organisme : University of California, Riverside (UCR)
ID : Startup Funds

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

James P Stumpff (JP)

Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.

Sang Yong Kim (SY)

Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521.

Matthew I McFadden (MI)

Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210.

Andrew Nishida (A)

Department of Microbiology, University of Washington, Seattle, WA 98109.

Roksana Shirazi (R)

Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.

Yael Steuerman (Y)

The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.

Irit Gat-Viks (I)

The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.

Adriana Forero (A)

Department of Microbial Infection and Immunity, College of Medicine, The Ohio State University, Columbus, OH 43210.
Infectious Diseases Institute, The Ohio State University, Columbus, OH 43210.

Meera G Nair (MG)

Division of Biomedical Sciences, School of Medicine, University of California, Riverside, CA 92521.

Juliet Morrison (J)

Department of Microbiology and Plant Pathology, University of California, Riverside, CA 92521.

Classifications MeSH